Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea

Yoojoo Lim1, Jeong Ok Lee1, Soo Mee Bang2

  • 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Insights

This study presents the first Korean nationwide statistics for myeloproliferative neoplasms (MPN), revealing increasing incidence and prevalence of polycythemia vera (PV), myelofibrosis (MF), and essential thrombocythemia (ET). MF showed the lowest survival rate.

Area of Science:

  • Hematology
  • Oncology
  • Epidemiology

Background:

  • Nationwide statistical data on classical myeloproliferative neoplasms (MPN) in Korea were previously unavailable.
  • Understanding the epidemiology of MPN is crucial for public health planning and resource allocation.

Purpose of the Study:

  • To analyze the incidence, survival rates, and treatment patterns of polycythemia vera (PV), primary myelofibrosis (MF), and essential thrombocythemia (ET) in Korea.
  • To establish the first comprehensive Korean nationwide statistics for MPN.

Main Methods:

  • Utilized the Korea National Cancer Incidence Database (KNCIDB) and Health Insurance Review and Assessment Service (HIRA) database.
  • Analyzed data from 2003 to 2011, covering 4,342 new MPN cases.
  • Calculated crude incidence rates, five-year relative survival rates, and treatment patterns.

Main Results:

  • Essential thrombocythemia (ET) was the most common MPN, followed by MF and PV.
  • Crude incidence rates for PV, MF, and ET increased from 2003-2011.
  • The five-year relative survival rate for all MPN was 89.3%, with MF having the lowest at 53.1%.
  • Hydroxyurea prescription rates were higher in patients over 60.

Conclusions:

  • This study provides the first Korean nationwide statistics for MPN, essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (MF).
  • Findings indicate increasing trends in MPN incidence and prevalence, with significant survival disparities among subtypes.
  • The data can inform international comparisons and guide clinical guidelines.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
692
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.2K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
688
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K